We found that thymosin β4 formed a functional complex with PINCH and integrin-linked kinase (ILK), resulting in activation of the survival kinase Akt (also known as protein kinase B).

Thymosin alpha-1 has been hypothesized to enhance the immune response to viruses and cancer cells by increasing T-cell development, antigen recognition, and activation.

RGN-259 is a thymosin beta-4–based eye drop designed to rival Dompé’s Oxervate, the only FDA-approved prescription eye drop ...

Thymosin α 1 (Tα1) is an immunomodulatory polypeptide that enhances effector T-cell responses. In this large randomized study, we evaluated the efficacy and safety of combining Tα1 with dacarbazine ...

Thymosin Alpha 1 Peptide: Modulation of Cytokine Production . Findings imply that Tα1 may have an impact on the cytokine microenvironment that exists inside the immune system.

An NPR investigation has identified a web of more than 30 medical practices and compounding pharmacies in over a dozen states that have made claims about thymosin alpha-1 online and on social media.

Thymosin alpha-1 (TA1) is an investigational drug in Phase II trials for the treatment of chronic hepatitis B and in Phase III trials for the treatment of chronic hepatitis C. Phase II trials for ...

Thymosin Alpha 1 (Tα-1), a well-established immunomodulator, is known to protect lymphocytes, reduce lymphocytopenia during radiotherapy, and enhance T lymphocytes. This study aims to evaluate the ...

Thymosin beta 4 not on WADA banned list: Stephen Dank. By Jon Pierik. Updated March 29, 2015 — 5.09pm first published at 11.50am. Save. Log in, register or subscribe to save articles for later.